| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000009652 |
| Receipt No. | R000011327 |
| Scientific Title | Cooperation system between hospital and pharmacy in chronic kidney disease |
| Date of disclosure of the study information | 2012/12/27 |
| Last modified on | 2019/07/03 (Ver. 7) |
| Basic information | ||
| Public title | Cooperation system between hospital and pharmacy in chronic kidney disease | |
| Acronym | Cooperation system between hospital and pharmacy in chronic kidney disease | |
| Scientific Title | Cooperation system between hospital and pharmacy in chronic kidney disease | |
| Scientific Title:Acronym | Cooperation system between hospital and pharmacy in chronic kidney disease | |
| Region |
|
|
| Condition | |||
| Condition | chronic kidney disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the effect of CKD patients instruction on medication adherence |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | medication adherence |
| Key secondary outcomes | ambulatory rate of medical record, blood pressure, blood sugar, HbA1c, nonHDL-C, Cr, eGFR, patient satisfaction
|
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | usual medical instruction | |
| Interventions/Control_2 | medical instruction with information of CKD | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. CKD patients
2. patients who can attend this hospital 3. patients who had already used the attend pharmacy 4. patients who understand this study |
|||
| Key exclusion criteria | 1. patients who can not understand this study
2. patient who will move to ohter hospital |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba, Division of clinical medicine, Faculty of medicine | ||||||
| Division name | Department of nephrology | ||||||
| Zip code | 305-8575 | ||||||
| Address | 1-1-1, Tennodai, Tsukuba, Ibaraki, Japan | ||||||
| TEL | 029-853-3202 | ||||||
| k-yamaga@md.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Tsukuba, Division of clinical medicine, Faculty of medicine | ||||||
| Division name | Department of nephrology | ||||||
| Zip code | 305-8575 | ||||||
| Address | 1-1-1, Tennodai, Tsukuba, Ibaraki, Japan | ||||||
| TEL | 029-853-3202 | ||||||
| Homepage URL | |||||||
| chie.saito@md.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | University of Tsukuba Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grant-in-Aid for Scientific Research (KAKENHI) |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tsukuba Clinical Research and Development Organization |
| Address | 2-1-1,Amakubo, Tsukuba, Ibaraki, Japan |
| Tel | 029-853-3914 |
| chiken@un.tsukuba.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 筑波大学附属病院(茨城県)、調剤薬局(茨城県つくば市) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011327 |